TY - JOUR
T1 - Head-to-head prenyl tranferases
T2 - Anti-infective drug targets
AU - Lin, Fu Yang
AU - Liu, Yi Liang
AU - Li, Kai
AU - Cao, Rong
AU - Zhu, Wei
AU - Axelson, Jordan
AU - Pang, Ran
AU - Oldfield, Eric
PY - 2012/5/10
Y1 - 2012/5/10
N2 - We report X-ray crystallographic structures of three inhibitors bound to dehydrosqualene synthase from Staphylococcus aureus: 1 (BPH-651), 2 (WC-9), and 3 (SQ-109). Compound 2 binds to the S2 site with its -SCN group surrounded by four hydrogen bond donors. With 1, we report two structures: in both, the quinuclidine headgroup binds in the allylic (S1) site with the side chain in S2, but in the presence of PPi and Mg 2+, the quinuclidine's cationic center interacts with PPi and three Mg 2+, mimicking a transition state involved in diphosphate ionization. With 3, there are again two structures. In one, the geranyl side chain binds to either S1 or S2 and the adamantane headgroup binds to S1. In the second, the side chain binds to S2 while the headgroup binds to S1. These results provide structural clues for the mechanism and inhibition of the head-to-head prenyl transferases and should aid future drug design.
AB - We report X-ray crystallographic structures of three inhibitors bound to dehydrosqualene synthase from Staphylococcus aureus: 1 (BPH-651), 2 (WC-9), and 3 (SQ-109). Compound 2 binds to the S2 site with its -SCN group surrounded by four hydrogen bond donors. With 1, we report two structures: in both, the quinuclidine headgroup binds in the allylic (S1) site with the side chain in S2, but in the presence of PPi and Mg 2+, the quinuclidine's cationic center interacts with PPi and three Mg 2+, mimicking a transition state involved in diphosphate ionization. With 3, there are again two structures. In one, the geranyl side chain binds to either S1 or S2 and the adamantane headgroup binds to S1. In the second, the side chain binds to S2 while the headgroup binds to S1. These results provide structural clues for the mechanism and inhibition of the head-to-head prenyl transferases and should aid future drug design.
UR - http://www.scopus.com/inward/record.url?scp=84861089202&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861089202&partnerID=8YFLogxK
U2 - 10.1021/jm300208p
DO - 10.1021/jm300208p
M3 - Article
C2 - 22486710
AN - SCOPUS:84861089202
SN - 0022-2623
VL - 55
SP - 4367
EP - 4372
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 9
ER -